Effects of Quercetin on Cardiometabolic Health
Official title: Effects of Quercetin Supplementation on Cardiometabolic Parameters
Run by University of Central Lancashire · NCT06230861 · Data updated 2026-11-12
This study tests if taking Quercetin can help improve heart and metabolic health in healthy adults aged 18 to 65 compared to a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Central Lancashire Academic / other |
| Locations | 1 site (Preston, Lancashire) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | August 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT06230861 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy adults aged 18 to 65 with a BMI under 30 who do not smoke.
✕Probably not a fit
Patients with diabetes, uncontrolled hypertension, or those who are pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the potential benefits of Quercetin, a natural compound, on improving cardiometabolic outcomes in healthy adults. Participants aged 18 to 65 will be randomly assigned to receive either Quercetin or a placebo, allowing researchers to assess its effects on cardiovascular health and metabolic function. The study aims to provide a safer dietary intervention compared to traditional pharmacological treatments for cardiometabolic syndrome. By focusing on a placebo-controlled design, the research seeks to establish a clearer understanding of Quercetin's efficacy.
Why it matters
Potential benefit: If successful, this study could offer a natural dietary intervention to improve cardiometabolic health and reduce the risk of related diseases.
How similar studies have gone: While dietary interventions for cardiometabolic health are common, this specific approach using Quercetin in a placebo-controlled setting is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy * Between 18 \& 65 years * BMI \< 30 * Able to give informed consent Exclusion Criteria: * Pregnancy * Diabetes or any other metabolic/ uncontrolled hypertensive conditions * Food allergies to quercetin * Habitual consumption of quercetin * Not regularly taking medication or antioxidant supplements
Where it's running
-
University of Central Lancashire
Preston, Lancashire, United Kingdom Recruiting
Study contacts
- Study coordinator: Jonathan Sinclair, PhD, DSc
- Email: jksinclair@uclan.ac.uk
- Phone: +447875651533
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimizing LDL cholesterol levels using inclisiran for patients with drug interactions
This study is testing if inclisiran can help lower LDL cholesterol in patients with multiple health issues who can't take statins due to other medications.
-
Investigating how ectopic fat affects heart attack risk in people living with HIV
This study looks at how extra fat around organs affects the risk of heart attacks in people living with HIV to help improve their heart health.
-
FEAST Perinatal Support Program for Pregnant and Postpartum People
This program tries a community-based combination of dietary education, skills training, social support, and grocery gift cards for pregnant people on WIC/EBT to help them eat healthier and feel better during pregnancy and postpartum.
-
Imaging metabolic processes in the body using Carbon-13 pyruvate
This study is testing a new type of MRI using a special substance to see if it can help us understand how the body processes energy in people with heart problems and healthy volunteers without using harmful radiation.
-
Effects of Chardonnay Marc on gut and heart health
This study is testing if adding Chardonnay grape skins and seeds to the diet can improve gut and heart health in obese postmenopausal women.
-
Biobank of stem cells and biomarkers for cardiovascular disease
This study is creating a bank of stem cells and blood samples from people with heart disease to help researchers learn more about the condition and find better treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.